Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1ANDROST BIOTECH PRIVATE LIMITED
03 1HORSTER BIOTEK PVT LTD.
04 1KALCHEM INTERNATIONAL INC
05 1LETCO MEDICAL, LLC
06 1Pharma Source Direct, Inc.
07 1SCH Global Services Private Limited
08 1STHREE CHEMICALS PRIVATE LIMITED
09 1Steroid S.p.A.
10 3Symed Labs Limited
01 3STANOZOLOL
02 8Stanozolol
03 1Stanozolol Micronized
01 4India
02 1Italy
03 2U.S.A
04 5Blank
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-110
Start Marketing Date : 2025-03-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-246
Start Marketing Date : 2020-02-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-3068
Start Marketing Date : 2013-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49803-004
Start Marketing Date : 2025-01-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10000g/10000g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0205
Start Marketing Date : 1984-05-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0205
Start Marketing Date : 1984-05-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0205
Start Marketing Date : 1984-05-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 83511-008
Start Marketing Date : 2025-03-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 85207-009
Start Marketing Date : 2025-06-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 82393-503
Start Marketing Date : 2025-04-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
73
PharmaCompass offers a list of Stanozolol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Stanozolol manufacturer or Stanozolol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Stanozolol manufacturer or Stanozolol supplier.
PharmaCompass also assists you with knowing the Stanozolol API Price utilized in the formulation of products. Stanozolol API Price is not always fixed or binding as the Stanozolol Price is obtained through a variety of data sources. The Stanozolol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole, including repackagers and relabelers. The FDA regulates 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole supplier is an individual or a company that provides 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole active pharmaceutical ingredient (API) or 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole finished formulations upon request. The 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole suppliers may include 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole API manufacturers, exporters, distributors and traders.
click here to find a list of 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole suppliers with NDC on PharmaCompass.
We have 5 companies offering 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole
Get in contact with the supplier of your choice:
